Zobrazeno 1 - 10
of 81
pro vyhledávání: '"J J Ochs"'
Autor:
J, Fontanesi, R L, Heideman, M, Muhlbauer, R, Mulhern, R A, Sanford, E C, Douglass, E, Kovnar, J J, Ochs, J F, Kuttesch, D, Tai
Publikováno v:
Pediatric neurosurgery. 22(6)
Malignant pediatric tumors of the central nervous system (CNS) have a poor prognosis, with local failure rates as high as 50%. In an attempt to improve local tumor control, we used stereotactic interstitial therapy with 125I implants in patients with
Autor:
J J Ochs, M Fer, Deborah K. Mayer, GC Bottino, Kenneth A. Foon, Paul G. Abrams, DJ Carlo, Paul A. Bunn, Robert W. Schroff, SA Sherwin
Publikováno v:
Blood. 64:1085-1093
A phase I clinical trial was initiated to treat patients with stage IV B-derived chronic lymphocytic leukemia (CLL) with the IgG2a murine monoclonal antibody T101. This antibody binds to a 65,000-mol wt (T65) antigen found on normal T lymphocytes, ma
Publikováno v:
The Journal of Immunology. 132:1611-1613
Human-murine hybridomas, generated by fusion of human CLL cells with non-Ig-secreting murine myeloma NS-1, and secreting the IgM kappa expressed on the CLL cell surface, were grown in the peritoneal cavity of doubly pristane-primed nude mice to produ
Publikováno v:
Cancer. 45(9)
Central nervous system (CNS) "prophylaxis" is critical in the treatment of acute lymphocytic leukemia (ALL). The standard method employed combines cranial radiation (CRT) and intrathecal methotrexate (IT MTX). Recently, a 52% incidence of abnormal co
Publikováno v:
Cancer treatment reports. 62(2)
Eight patients with advanced metastatic osteogenic sarcoma were treated with cis-dichlorodiammineplatinum(II) (DDP). Prior to DDP, seven patients had amputations and all had received adjuvant adriamycin (ADR) therapy. In addition, prior to DDP, six p
Autor:
G. K. Rivera, E. Kovnar, C.-H. Pui, G. V. Dahl, M. Abromowitch, J. J. Ochs, A. T. Look, D. K. Kalwinsky, J. Mirro, L. W. Dow, S. B. Murphy
Publikováno v:
Acute Leukemias ISBN: 9783540165569
The leukemias of childhood have provided an excellent model with which to test novel therapeutic strategies for human neoplasias [1]. In 1984, we devised an intensive multi-drug regimen for treatment of newly diagnosed patients with acute lymphocytic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a176ba2d234ce1e0bf435058f808edf
https://doi.org/10.1007/978-3-642-71213-5_23
https://doi.org/10.1007/978-3-642-71213-5_23
Autor:
S A, Sherwin, J A, Knost, S, Fein, P G, Abrams, K A, Foon, J J, Ochs, C, Schoenberger, A E, Maluish, R K, Oldham
Publikováno v:
JAMA. 248(19)
Eighty-one patients with a variety of refractory disseminated malignant neoplasms have been treated in the first multiple fixed-dose phase I trial of recombinant leukocyte A interferon (IFL-rA). Each patient received IFL-rA by intramuscular injection
Publikováno v:
The American journal of medicine. 77(2)
Two patients with advanced lymphoma involving the lungs that was resistant to chemotherapy had an initial excellent response to interferon therapy. After two months of stable disease, alpha interferon A therapy was discontinued, with relapse of a few
Autor:
S A, Sherwin, K A, Foon, P G, Abrams, M R, Heyman, J J, Ochs, T, Watson, A, Maluish, R K, Oldham
Publikováno v:
Journal of biological response modifiers. 3(6)
Thirty-three patients were treated in an escalating single-dose trial of partially purified nonrecombinant interferon-gamma (IFN-gamma). The first seven patients received intramuscular injections of IFN-gamma in doses up to 20 X 10(6) units/m2. When
Autor:
G K, Rivera, E, Kovnar, C H, Pui, G V, Dahl, M, Abromowitch, J J, Ochs, A T, Look, D K, Kalwinsky, J, Mirro, L W, Dow
Publikováno v:
Haematology and blood transfusion. 30